Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
The Lancet (2016) Vol. 388, Iss. 10059, pp. 2532-2561
Open Access | Times Cited: 1616

Showing 1-25 of 1616 citing articles:

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6803
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 5427
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 18, pp. 1713-1722
Open Access | Times Cited: 4956
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4190
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
Atherosclerosis (2019) Vol. 290, pp. 140-205
Open Access | Times Cited: 4150
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham, et al.
European Heart Journal (2017) Vol. 38, Iss. 32, pp. 2459-2472
Open Access | Times Cited: 2983
Atherosclerosis
Peter Libby, Julie E. Buring, Lina Badimón, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2192
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Journal of the American College of Cardiology (2018) Vol. 73, Iss. 24, pp. e285-e350
Open Access | Times Cited: 2084
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1782
The changing landscape of atherosclerosis
Peter Libby
Nature (2021) Vol. 592, Iss. 7855, pp. 524-533
Closed Access | Times Cited: 1602
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Journal of the American College of Cardiology (2018) Vol. 73, Iss. 24, pp. 3168-3209
Open Access | Times Cited: 1342
Biomarker definitions and their applications
Robert M. Califf
Experimental Biology and Medicine (2018) Vol. 243, Iss. 3, pp. 213-221
Open Access | Times Cited: 1079
Facing up to the global challenges of ageing
Linda Partridge, Joris Deelen, P. Eline Slagboom
Nature (2018) Vol. 561, Iss. 7721, pp. 45-56
Closed Access | Times Cited: 1070
Stroke
Graeme J. Hankey
The Lancet (2016) Vol. 389, Iss. 10069, pp. 641-654
Closed Access | Times Cited: 1045
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Jennifer S. Lawton, Jacqueline E. Tamis-Holland, Sripal Bangalore, et al.
Journal of the American College of Cardiology (2021) Vol. 79, Iss. 2, pp. e21-e129
Open Access | Times Cited: 969
Effects of stress on the development and progression of cardiovascular disease
Mika Kivimäki, Andrew Steptoe
Nature Reviews Cardiology (2017) Vol. 15, Iss. 4, pp. 215-229
Open Access | Times Cited: 911
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

New England Journal of Medicine (2017) Vol. 377, Iss. 13, pp. 1217-1227
Open Access | Times Cited: 888
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Jennifer S. Lawton, Jacqueline E. Tamis‐Holland, Sripal Bangalore, et al.
Circulation (2021) Vol. 145, Iss. 3
Open Access | Times Cited: 839
Reducing the Global Burden of Cardiovascular Disease, Part 1
Philip Joseph, Darryl P. Leong, Martin McKee, et al.
Circulation Research (2017) Vol. 121, Iss. 6, pp. 677-694
Closed Access | Times Cited: 816
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 683
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease
Marc P. Bonaca, Patrice Nault, Robert P. Giugliano, et al.
Circulation (2017) Vol. 137, Iss. 4, pp. 338-350
Open Access | Times Cited: 660
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G. Richardson, Eleanor Sanderson, Tom Palmer, et al.
PLoS Medicine (2020) Vol. 17, Iss. 3, pp. e1003062-e1003062
Open Access | Times Cited: 653
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, et al.
The Lancet (2019) Vol. 393, Iss. 10170, pp. 407-415
Open Access | Times Cited: 652
Atherosclerosis and inflammation: overview and updates
Glaucylara Reis Geovanini, Peter Libby
Clinical Science (2018) Vol. 132, Iss. 12, pp. 1243-1252
Closed Access | Times Cited: 625
Page 1 - Next Page

Scroll to top